Cargando…

Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program

Population genomic screening has been demonstrated to detect at-risk individuals who would not be clinically identified otherwise. However, there are concerns about the increased utilization of unnecessary services and the associated increase in costs. The objectives of this study are twofold: (1) d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Jing, Hassen, Dina, Manickam, Kandamurugu, Murray, Michael F., Hartzel, Dustin N., Hu, Yirui, Liu, Kunpeng, Rahm, Alanna Kulchak, Williams, Marc S., Lazzeri, Amanda, Buchanan, Adam, Sturm, Amy, Snyder, Susan R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151600/ https://www.ncbi.nlm.nih.gov/pubmed/32028596 http://dx.doi.org/10.3390/jpm10010007

Ejemplares similares

Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review
por: Buchanan, Adam Hudson, et al.
Publicado: (2016)

Understanding the Patient Experience of Receiving Clinically Actionable Genetic Results from the MyCode Community Health Initiative, a Population-Based Genomic Screening Initiative
por: Baker, Anna, et al.
Publicado: (2022)

Exome Sequencing–Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants
por: Manickam, Kandamurugu, et al.
Publicado: (2018)

Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H, et al.
Publicado: (2017)

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment
por: Jones, Laney K., et al.
Publicado: (2020)

Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants
por: Buchanan, Adam H., et al.
Publicado: (2021)

Economic Evaluation of Universal Lynch Syndrome Screening Protocols among Newly Diagnosed Patients with Colorectal Cancer
por: Hao, Jing, et al.
Publicado: (2021)

A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System
por: Jones, Laney K., et al.
Publicado: (2022)

Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents
por: Savatt, Juliann M., et al.
Publicado: (2020)

Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction
por: Jones, Laney K., et al.
Publicado: (2022)

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis
por: Jones, Laney K., et al.
Publicado: (2021)

Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis
por: Jones, Laney K., et al.
Publicado: (2021)

Disorders of Gut-Brain Interaction in a National Cohort of Children With Down Syndrome
por: Ciciora, Steven L, et al.
Publicado: (2023)

Clinical outcomes of a genomic screening program for actionable genetic conditions
por: Buchanan, Adam H., et al.
Publicado: (2020)

The Healthcare Systems Research Network (HCSRN) as an Environment for Dissemination and Implementation Research: A Case Study of Developing a Multi-Site Research Study in Precision Medicine
por: Rahm, Alanna Kulchak, et al.
Publicado: (2019)

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol
por: Jones, Laney K., et al.
Publicado: (2022)

Generation and Implementation of a Patient-Centered and Patient-Facing Genomic Test Report in the EHR
por: Goehringer, Jessica M., et al.
Publicado: (2018)

Developing Pharmacogenomic Reports: Insights from Patients and Clinicians
por: Jones, Laney K., et al.
Publicado: (2018)

Enhancing genomic laboratory reports from the patients' view: A qualitative analysis
por: Stuckey, Heather, et al.
Publicado: (2015)

Enhancing genomic laboratory reports: A qualitative analysis of provider review
por: Williams, Janet L., et al.
Publicado: (2016)

Impact of a Patient-Facing Enhanced Genomic Results Report to Improve Understanding, Engagement, and Communication
por: Williams, Janet L., et al.
Publicado: (2017)

A mainstreaming oncogenomics model: improving the identification of Lynch syndrome
por: O’Shea, Rosie, et al.
Publicado: (2023)

Generation of an induced pluripotent stem cell line (NCHi010-A) from a 6-year-old female with Down syndrome and without congenital heart disease
por: Yu, Yang, et al.
Publicado: (2023)

Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories
por: Feigelson, Heather Spencer, et al.
Publicado: (2012)

“Go ahead and screen” - advice to healthcare systems for routine lynch syndrome screening from interviews with newly diagnosed colorectal cancer patients
por: Schneider, Jennifer L., et al.
Publicado: (2023)

Rurality, Death, and Healthcare Utilization in Heart Failure in the Community
por: Manemann, Sheila M., et al.
Publicado: (2021)

Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2014)

Association Between Psychiatric Polygenic Scores, Healthcare Utilization and Comorbidity Burden
por: Kirchner, H. Lester, et al.
Publicado: (2023)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Self‐Rated Health Predicts Healthcare Utilization in Heart Failure
por: Chamberlain, Alanna M., et al.
Publicado: (2014)

Patient experiences align with the familial hypercholesterolemia global call to action
por: Jones, Laney K., et al.
Publicado: (2022)

User testing of a diagnostic decision support system with machine-assisted chart review to facilitate clinical genomic diagnosis
por: Kulchak Rahm, Alanna, et al.
Publicado: (2021)

Investigating Psychological Impact after Receiving Genetic Risk Results—A Survey of Participants in a Population Genomic Screening Program
por: McCormick, Cara Zayac, et al.
Publicado: (2022)

Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts
por: Rahm, Alanna Kulchak, et al.
Publicado: (2018)

Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer
por: Biskupiak, Joseph, et al.
Publicado: (2021)

Genome instability in blood cells of a BRCA1+ breast cancer family
por: Xiao, Fengxia, et al.
Publicado: (2014)

De novo loss-of-function variants in NSD2 (WHSC1) associate with a subset of Wolf–Hirschhorn syndrome
por: Barrie, Elizabeth S., et al.
Publicado: (2019)

Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation
por: Mansfield, Carol A., et al.
Publicado: (2020)

Utility of specific amino acid ratios in screening for pyruvate dehydrogenase complex deficiencies and other mitochondrial disorders associated with congenital lactic acidosis and newborn screening prospects
por: Bedoyan, Jirair K., et al.
Publicado: (2020)

Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus
por: Pasternak, Amy L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_726kei07f39v4h14oqr5rt4951